Foundry Partners LLC Increases Stock Position in AdaptHealth Corp. (NASDAQ:AHCO)

Foundry Partners LLC boosted its holdings in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 6.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 804,011 shares of the company's stock after buying an additional 48,804 shares during the period. Foundry Partners LLC owned approximately 0.60% of AdaptHealth worth $7,654,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Assetmark Inc. purchased a new position in AdaptHealth in the 4th quarter worth $28,000. Blue Trust Inc. raised its stake in shares of AdaptHealth by 24.1% in the fourth quarter. Blue Trust Inc. now owns 5,746 shares of the company's stock worth $55,000 after purchasing an additional 1,115 shares during the last quarter. Quarry LP boosted its position in AdaptHealth by 4,596.9% in the third quarter. Quarry LP now owns 5,965 shares of the company's stock valued at $67,000 after buying an additional 5,838 shares during the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management increased its holdings in AdaptHealth by 15.4% in the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company's stock worth $121,000 after buying an additional 1,690 shares during the period. Finally, KLP Kapitalforvaltning AS purchased a new position in AdaptHealth during the 4th quarter worth approximately $169,000. 82.67% of the stock is currently owned by hedge funds and other institutional investors.

AdaptHealth Trading Down 2.8 %

NASDAQ AHCO traded down $0.25 on Wednesday, reaching $8.75. 337,498 shares of the company were exchanged, compared to its average volume of 1,199,522. The company has a current ratio of 1.24, a quick ratio of 1.00 and a debt-to-equity ratio of 1.34. The business's fifty day moving average price is $9.95 and its 200 day moving average price is $10.10. The stock has a market capitalization of $1.18 billion, a P/E ratio of -5.29, a price-to-earnings-growth ratio of 1.08 and a beta of 1.44. AdaptHealth Corp. has a fifty-two week low of $8.35 and a fifty-two week high of $11.90.

Analyst Ratings Changes

AHCO has been the subject of several recent research reports. Robert W. Baird raised their target price on shares of AdaptHealth from $14.00 to $16.00 and gave the stock an "outperform" rating in a report on Thursday, February 27th. Royal Bank of Canada upped their target price on AdaptHealth from $11.00 to $14.00 and gave the stock an "outperform" rating in a research note on Wednesday, February 26th. Canaccord Genuity Group lifted their price target on AdaptHealth from $13.00 to $14.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. UBS Group lowered their price objective on AdaptHealth from $12.00 to $11.00 and set a "buy" rating on the stock in a research report on Thursday, February 13th. Finally, Truist Financial lifted their target price on shares of AdaptHealth from $12.00 to $14.00 and gave the company a "buy" rating in a report on Wednesday, February 26th. Five investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company presently has an average rating of "Buy" and an average price target of $13.80.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.